Schedule a complimentary 30-minute consultation about your next lay language trial results summary

Join the patient engagement movement of pharmaceutical and biotech companies that are taking time to inform study volunteers about what was learned from their participation in clinical trials. More than 30 of the top pharma companies have partnered with CISCRP for creating and delivering lay language summaries that are non-promotional, unbiased, and written in a way that participants will understand and appreciate.

Give back to the participants who gave you their time by starting with a free 30-minute consultation with CISCRP to discuss:

  • Information about the trial(s) you wish to provide lay language summary results
  • An overview of our proven and efficient lay language summary process
  • The current state of the lay summary regulatory landscape
  • Next steps for getting started, including a CISCRP proposal

Phone: (617) 725-2750
Toll Free: (877) MED-HERO (633-4376)

Schedule my 30-minute consultation
We’ll be in touch within 24 hours

Why communicate your trial results to participants?

Participants want to know what was learned from their participation in a trial

84% of clinical trial participants said it is ‘very important’ or ‘somewhat important’ to receive the results of their clinical trial1

Patients need lay language summaries to comprehend the technical results

91% of clinical trial participants understood the results of their trial well after reviewing a lay language summary when prior to review, basic facts about the trial were understood by less than 11%.2

Lack of communication may negatively impact the clinical research enterprise

91% of clinical trial participants want to be informed about research findings from their trial and would reportedly not participate in future clinical trials if left uninformed. 3

Why partner with CISCRP for your lay language summaries?

We’re independent and trusted

Since we’re not vested in the outcome of the trial, we are dedicated to ensuring every lay language or plain language summary we provide is non-promotional and unbiased toward the drug, product, or sponsor. Our team is fully committed to these goals and we specifically dedicate time and resources to developing practical and ethical approaches to share with sponsors.

We’re proven and experienced

We’ve developed and delivered over [50,000 trial results communications] to over 40 countries around the world, generating best practices that we can apply for the benefit of all of our partners.

We’re committed to patient representation through our Editorial Panel

Every trial results summary we provide is reviewed by an Editorial Panel compromised of patients, members of therapeutic area specialists. This type of user-testing allows us to follow a universal best practice in patient and public communication by ensuring the materials we provide are understandable, clear, comprehensive and are not perceived to be promotional or bias.

We’re continually trained in specialized health communications

Our team has specialized training in content and design principles that arise from the rapidly developing academic field of health communication. We continually develop and operationalize these distinct skill sets to differentiate our capabilities from traditional, technical medical writers and communications service providers. This allows us to produce materials that meet the needs of various audiences by following best practices in patient, public, and lay person communication.

What Our Clients Say About Our Program

"Returning clinical trial results to our study volunteers is an essential part of our patient centric activity. We’ve been very pleased with CISCRP’s program and customer service."
– Mid-sized pharmaceutical company

"CISCRP’s knowledge and expertise is unprecedented. They have been so easy to work with and the program easily incorporates into our operations."
– Top 25 pharmaceutical company

"We were concerned about implementing a lay summary program for all the trials in our portfolio. CISCRP brought the expertise and knowledge to guide us through the process"
– Large biotechnology company

About Our Communicating Trial Results Program

A growing number of pharmaceutical, biotechnology and medical device companies are now providing clinical trial results summaries to their study participants. Since 2009, CISCRP has helped these companies create and deliver accurate summaries and promote positive clinical trial experiences. As an independent non-profit dedicated to public and patient engagement, CISCRP is uniquely positioned to provide non-promotional and unbiased plain language trial results summaries guided by a high-quality, patient-focused editorial process. CISCRP’s program follows a proprietary and proven method that remains compliant with regulatory requirements including the anticipated European Union mandate; fully addresses patient protections; accommodates sponsor company specifications; and integrates easily into sponsor company’s operating practices.


The Center for Information and Study on Clinical Research Participation (CISCRP) was founded in 2003 and is a first-of-its-kind nonprofit organization dedicated to educating and informing the public, patients, medical/research communities, the media, and policy makers about clinical research and the role each party plays in the process.


  1. 2017 CISCRP P&I Study, n=12,427.
  2. Getz et al. 2012. Expert Rev. Clin. Pharmacol. 5(2): 149-156.
  3. Sood et al. 2009. Mayo Clinic Proceedings. 84(3): 243-247.